3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
2
Status
Completed
1
Active not recruiting
1
Sponsor Class
INDUSTRY
2
Study Type
Interventional
2
Sponsor
Cancer Type
Head & Neck
1
Dermatologic
1
Conditions
Squamous Cell Carcinoma of Head and Neck
1
Melanoma
1
Adenoviridae Infections
1
Interventions
pembrolizumab
1268
Specimen Handling
871
Carboplatin
831
Magnetic Resonance Spectroscopy
805
Cyclophosphamide
802
Cisplatin
728
Nivolumab
658
Paclitaxel
630
Radiotherapy
573
Gemcitabine
571
Biopsy
529
Bevacizumab
476
Dexamethasone
440
fludarabine
406
Docetaxel
378
venetoclax
370
Oxaliplatin
365
Capecitabine
358
Fluorouracil
355
atezolizumab
344
durvalumab
333
Rituximab
332
Doxorubicin
317
Radiosurgery
309
Pemetrexed
306
Drug Therapy
302
Ipilimumab
294
Standard of Care
293
Etoposide
284
Radiation
281
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Interventional
×
Tumor Necrosis Factor-alpha
×
1 year
×
Clear all
NCT04695327
2026-03-06
TUNIMO
TILT Biotherapeutics Ltd.
Phase 1
Completed
32 enrolled
NCT05222932
2025-08-07
AVENTIL
TILT Biotherapeutics Ltd.
Phase 1
Active not recruiting
15 enrolled